<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Skip to content

Autologous Tumor Infiltrating Lymphocyte (TIL) Platform

A Champions Research Platform

Champions' innovative platform enables Immuno-Oncology researchers the ability to test their therapeutics in a 3D assay that can mimic mechanisms of action.

The Autologous TIL platform is an ex vivo 3D co-culture platform developed and optimized to interrogate the responses of your Immuno-Oncology drugs with a tumor-specific microenvironment in only 4 days using TumorGraft3D models collected with matched, autologous TIL samples.







Download the Platform Sheet